These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3222164)

  • 1. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
    Danziger LH; Creger RJ; Shwed JA; Stellato TA; Hau T
    Pharmacotherapy; 1988; 8(6):315-8. PubMed ID: 3222164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
    Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
    Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
    Solomkin JS; Fant WK; Rivera JO; Alexander JW
    Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients.
    Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E
    Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
    Larsen JW; Gabel-Hughes K; Kreter B
    Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin versus gentamicin/clindamycin: a cost effectiveness study.
    Norrby SR; Eriksson M; Ottosson E
    Scand J Infect Dis; 1986; 18(4):371-4. PubMed ID: 3094139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE; Nord CE
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.
    Lancet; 1984 Apr; 1(8382):868-71. PubMed ID: 6143185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
    Solomkin JS; Dellinger EP; Christou NV; Busuttil RW
    Ann Surg; 1990 Nov; 212(5):581-91. PubMed ID: 2241313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
    Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):683-92. PubMed ID: 1425726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D; Buchmann P; Geroulanos S
    Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.
    Ahonkhai VI; Cyhan GM; Wilson SE; Brown KR
    Pediatr Infect Dis J; 1989 Nov; 8(11):740-4. PubMed ID: 2687787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.
    Chen Z; Wu J; Zhang Y; Wei J; Leng X; Bi J; Li R; Yan L; Quan Z; Chen X; Yu Y; Wu Z; Liu D; Ma X; Maroko R; Cooper A
    BMC Infect Dis; 2010 Jul; 10():217. PubMed ID: 20663130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.